Journal article
Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke Risk
Abstract
BACKGROUND AND PURPOSE: In ACTIVE-W, oral anticoagulation (OAC) was more efficacious than combined clopidogrel plus aspirin (C+A) in preventing vascular events in patients with atrial fibrillation. However, because OAC carries important bleeding complications, risk stratification schemes have been devised to identify patients for whom the absolute benefits of OAC exceed its risks.
METHODS: Participants were risk-stratified with the widely-used …
Authors
Healey JS; Hart RG; Pogue J; Pfeffer MA; Hohnloser SH; De Caterina R; Flaker G; Yusuf S; Connolly SJ
Journal
Stroke, Vol. 39, No. 5, pp. 1482–1486
Publisher
Wolters Kluwer
Publication Date
5 2008
DOI
10.1161/strokeaha.107.500199
ISSN
0039-2499
Associated Experts
Fields of Research (FoR)
Medical Subject Headings (MeSH)
AgedAngiotensin II Type 1 Receptor BlockersAnticoagulantsAspirinAtrial FibrillationBiphenyl CompoundsCerebral HemorrhageClinical ProtocolsClopidogrelDrug CombinationsDrug Therapy, CombinationFemaleHumansIrbesartanMaleMiddle AgedPlatelet Aggregation InhibitorsRisk AssessmentRisk FactorsStrokeTetrazolesTiclopidineTreatment OutcomeWarfarin